Martin Werner

Title: Martin Werner: Innovator in Pharmaceutical Solutions

Introduction

Martin Werner is a notable inventor based in Uetersen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solutions for treating exocrine pancreatic insufficiency. His work is especially relevant for patients with cystic fibrosis and in pediatric care.

Latest Patents

Martin Werner holds a patent for an "Aqueous solution of burlulipase comprising calcium ions." This invention relates to an aqueous solution that contains burlulipase and is characterized by the inclusion of calcium ions. The pharmaceutical applications of this invention are aimed at treating conditions associated with exocrine pancreatic insufficiency. Furthermore, the patent also covers container-packaged solutions produced by the blow-fill-seal method, enhancing the delivery of these pharmaceuticals.

Career Highlights

Throughout his career, Martin Werner has worked with reputable companies such as Nordmark Pharma GmbH and Nordmark Arzneimittel GmbH & Co. KG. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Martin has collaborated with professionals like Richard Fuhrherr and Annika Müller-Lucks. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Martin Werner's contributions to pharmaceutical innovations demonstrate his commitment to improving patient care through scientific advancements. His patent for an aqueous solution of burlulipase is a testament to his ingenuity and dedication to addressing critical health issues.